期刊
ACTA BIOMATERIALIA
卷 68, 期 -, 页码 308-319出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.actbio.2017.12.034
关键词
Gold nanoclusters; Chlorin e6; Doxorubicin; MMP2 peptides; Targeted imaging; Chemo-photodynamic therapy
资金
- National Basic Research Program (973 Project) [2015CB931802]
- National Key Research and Development Program of China [2017FYA0205301]
- National Natural Scientific Foundation of China [81401458, 81225010, 81028009, 31170961]
- 863 projects of China [2014AA020701]
- China Postdoctoral Science Foundation [2017M621486]
- Shanghai Science and Technology Fund [14ZR1432400, 13NM1401500]
Nanoparticle-based drug delivery systems have drawn a great deal of attention for their opportunities to improve cancer treatments over intrinsic limits of conventional cancer therapies. Herein, we developed the polypeptide-modified gold nanoclusters (GNCs)-based nanoprobes for tumor-targeted near infrared fluorescence imaging and chemo-photodynamic therapy. The nanoprobes comprise of tetra-functional components: i) polyethylene glycol (PEG) shell for long blood circulation and better biocompatibility; ii) MMP2 polypeptide (CPLGVRGRGDS) for tumor targeting; iii) cis-aconitic anhydride-modified doxorubicin (CAD) for pH-sensitive drug release; iv) photosensitizer chlorin e6 (Ce6) for photodynamic therapy and fluorescence imaging. The in vitro results demonstrated that the as-synthesized nanoprobes could be efficiently internalized into A549 cells and then significantly enhance the mortality of cancer cells compared with free Ce6 and doxorubicin. For in vivo tests, the nanoprobes showed excellent tumor targeting ability, long blood circulation time, and could remarkably inhibit the growth of tumor. Our results will help to advance the design of combination strategies to enhance the efficacy of imaging-guided cancer therapy.(c) 2017 Published by Elsevier Ltd on behalf of Acta Materialia Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据